Research achievement
Domestic Patent Status
Scroll left and right to see.
| Number | Classification | Invention title | Registration number (Application number) | Registration date (Application date) |
|---|---|---|---|---|
| 1 | Application | Composition for self-emulsifying drug delivery system containing CoQ 10. | 10-2016-0045134 | 2016.04.12 |
| 2 | Composition for anticoagulant comprising wild parsley extract and anti-thrombotic agent. | 10-2017-0135472 | 2017.10.18 | |
| 3 | Composition for prevention or treatment of dementia, comprising compound K and decursinol. | 10-2018-0115748 | 2018.04.08 | |
| 4 | Registration | Macrolide antibiotics manufacturing method using novel intermediate agent. | 10-0317907 | 2001.12.05 |
| 5 | Tablet, formed by composition of Olanzapine and composition of extended release pallets containing Olanzapine. | 10-1244627 | 2013.03.12 | |
| 6 | Pharmaceutical composition containing ginsenoside sapogenin as an active ingredient. | 10-1889866 | 2018.08.13 | |
| 7 | Exclusive patent right | Composition for prevention or treatment inflammatory disease containing cell adhesion inhibitory substances isolated from black pepper as active ingredients. | 10-0954866 | 2010.04.19 |
| 8 | Composition for prevention and treatment of inflammatory disease containing cell adhesion inhibitory substances isolated from piper longum as active ingredients. | 10-0954865 | 2010.04.19 | |
| 9 | Composition for prevention or treatment of STAT 3 mediated disease containing extracts or fractions of common sage as an active ingredients. | 10-1487935 | 2015.01.23 | |
| 10 | Composition for prevention or treatment of IL-6 mediated disease containing extracts of fractions of portulaca extract as active ingredients. | 10-1577792 | 2015.12.09 | |
| 11 | Pharmaceutical composition for prevention or treatment of STAT 3 mediated disease containing sesquiterpene compounds as an active ingredient, and their use. | 10-1741017 | 2017.05.23 | |
| 12 | Pharmaceutical composition for prevention or treatment of STAT 3 mediated disease containing ursolic acid acetate as an active ingredient, and their use. | 10-1777770 | 2017.09.06 | |
| 13 | Pharmaceutical composition for prevention or treatment of STAT 3 mediated disease containing pterulone compounds as an active ingredient. | 10-1924737 | 2018.11.27 | |
| 14 | Oral administration agent for improvement of sexual function. | 10-2017-0169362 | 2017.12.11 | |
| 15 | Ordinary patent right | Oral administration agent for increasing sperm count. | 10-1144715 | 2012.05.03 |
| 16 | Composition for enhancing exercise performance. | 10-1557410 | 2015.09.25 | |
| 17 | Method of manufacturing injectable and eye drop solution forming homogeneous solution by solubilizing poorly soluble pharmacologically active ingredients. | 10-1717672 | 2017.03.13 | |
| 18 | Method of preparing homogeneous solution formation of poorly soluble pharmacologically active ingredient using ethanol and alkaline amino acid. | 10-1728799 | 2017.04.14 |
